15.91 -0.44 (-2.68%)
NUVA
| Trade NUVA now with |
Stock Details
Last Trade:15.91 Change:-0.44 (-2.68%) Prev Close:16.35 Open: 16.40 Days Range:15.84 – 16.41 52 Week Range: 11.02 - 34.91 Volume:505127 P/E: N/AEPS:-0.05
View AllRecent Alerts 02/09/12
Recent Alert on 01/26/12 at 6:46am
Medtronic (MDT) Injunction Against NuVasive (NUVA) Tentatively Denied in San Diego Court
Medtronic (MDT) Injunction Against NuVasive (NUVA) Tentatively Denied in San Diego Court
On January 25, 2012, a judge from the U.S. District Court, Southern District of California in San Diego (Case No. 3:08-cv-01512-MMA-MDD) delivered tentative and non-binding rulings on various post-trial motions, including Medtronic Sofamor Danek... Read More
Recent Alert on 01/26/12 at 6:46am
Medtronic (MDT) Injunction Against NuVasive (NUVA) Tentatively Denied in San Diego Court
Medtronic (MDT) Injunction Against NuVasive (NUVA) Tentatively Denied in San Diego Court
Recent Alert on 01/26/12 at 6:46am
Medtronic (MDT) Injunction Against NuVasive (NUVA) Tentatively Denied in San Diego Court
Medtronic (MDT) Injunction Against NuVasive (NUVA) Tentatively Denied in San Diego Court
Recent Alert on 01/25/12 at 3:09pm
NuVasive (NUVA) Shares Halted Up 19% as Bloomberg Says Medtronic (MDT) Tentatively Lost Injunction Ruling
NuVasive (NUVA) Shares Halted Up 19% as Bloomberg Says Medtronic (MDT) Tentatively Lost Injunction Ruling
Recent Alert on 01/25/12 at 3:09pm
NuVasive (NUVA) Shares Halted Up 19% as Bloomberg Says Medtronic (MDT) Tentatively Lost Injunction Ruling
NuVasive (NUVA) Shares Halted Up 19% as Bloomberg Says Medtronic (MDT) Tentatively Lost Injunction Ruling
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
SEC Filing on 02/09/12 at 4:17pm
Form SC 13G/A NUVASIVE INC Filed by: Capital Research Global Investors
Form SC 13G/A NUVASIVE INC Filed by: Capital Research Global Investors
View AllRecent Blog Posts
Blog Posts on 01/06/12 at 3:49pm
Integra LifeSciences Sputters At Year End, But Is Still Undervalued
Integra LifeSciences Sputters At Year End, But Is Still Undervalued


